Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Stiewe

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
The EMBO Journal|September 5, 2019
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responsesOleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
British Journal of Cancer|June 12, 2024
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinomaJan Budczies, Eva Romanovsky, Martina Kirchner, et al.
International Journal of Molecular Sciences|January 15, 2021
JAZF1, A Novel p400/TIP60/NuA4 Complex Member, Regulates H2A.Z Acetylation at Regulatory RegionsTara Procida, Tobias Friedrich, Antonia P M Jack, et al.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Science Advances|June 18, 2020
Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancerPoonam Sarode, Xiang Zheng, Georgia A Giotopoulou, et al.
Nature Chemical Biology|November 24, 2015
CRISPR-Cas9-based target validation for p53-reactivating model compoundsMichael Wanzel, Jonas B Vischedyk, Miriam P Gittler, et al.
Nucleic Acids Research|July 10, 2018
Histone variant H2A.Z deposition and acetylation directs the canonical Notch signaling responseBenedetto Daniele Giaimo, Francesca Ferrante, Diana M Vallejo, et al.
Cancer Research|August 21, 2020
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and InflammationNefertiti El-Nikhely, Annika Karger, Poonam Sarode, et al.
Molecular Oncology|June 14, 2020
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesionKaire Ojasalu, Corinna Brehm, Kristin Hartung, et al.
Cell Communication and Signaling : CCS|March 14, 2025
Basal cell adhesion molecule (BCAM) promotes mesothelial-to-mesenchymal transition and tumor angiogenesis through paracrine signalingSuresh Sivakumar, Sonja Lieber, Raimund Dietze, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
The EMBO Journal|September 5, 2019
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responsesOleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
British Journal of Cancer|June 12, 2024
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinomaJan Budczies, Eva Romanovsky, Martina Kirchner, et al.
International Journal of Molecular Sciences|January 15, 2021
JAZF1, A Novel p400/TIP60/NuA4 Complex Member, Regulates H2A.Z Acetylation at Regulatory RegionsTara Procida, Tobias Friedrich, Antonia P M Jack, et al.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR<sup>+</sup>/HER2<sup>-</sup> breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Science Advances|June 18, 2020
Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancerPoonam Sarode, Xiang Zheng, Georgia A Giotopoulou, et al.
Nature Chemical Biology|November 24, 2015
CRISPR-Cas9-based target validation for p53-reactivating model compoundsMichael Wanzel, Jonas B Vischedyk, Miriam P Gittler, et al.
Nucleic Acids Research|July 10, 2018
Histone variant H2A.Z deposition and acetylation directs the canonical Notch signaling responseBenedetto Daniele Giaimo, Francesca Ferrante, Diana M Vallejo, et al.
Cancer Research|August 21, 2020
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and InflammationNefertiti El-Nikhely, Annika Karger, Poonam Sarode, et al.
Molecular Oncology|June 14, 2020
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesionKaire Ojasalu, Corinna Brehm, Kristin Hartung, et al.
Cell Communication and Signaling : CCS|March 14, 2025
Basal cell adhesion molecule (BCAM) promotes mesothelial-to-mesenchymal transition and tumor angiogenesis through paracrine signalingSuresh Sivakumar, Sonja Lieber, Raimund Dietze, et al.
Pageof 17